Showing results (1201-1210 of 1,342) with videos related to

Sort By:
Pageof 135
Neuro-Oncology Advances|May 5, 2021
MR1 overexpression correlates with poor clinical prognosis in glioma patientsPhillip Kubica, Montserrat Lara-Velazquez, Marpe Bam, et al.
Neuro-Oncology Advances|August 19, 2021
Clinical and molecular analysis of smoothened inhibitors in Sonic Hedgehog medulloblastomaVictor Pereira, Jacob Torrejon, Dulanjalee Kariyawasam, et al.
Neuro-Oncology Advances|August 22, 2025
First-in-human study of an EGFRvIII x CD3 T cell bispecific antibody in the treatment of newly diagnosed glioblastomaJames R Whittle, Maria Vieito, Kristoffer Rohrberg, et al.
Neuro-Oncology Advances|August 22, 2025
Bridging the clinical gap: Confidence informed IDH prediction in brain gliomas using MRI and deep learningChandan Ganesh Bangalore Yogananda, Nghi C D Truong, Benjamin C Wagner, et al.
Neuro-Oncology Advances|January 30, 2026
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastomaJohn Y Rhee, Juan Pablo Ospina Botero, Thomas Nelson, et al.
Neuro-Oncology Advances|January 27, 2026
Fusion transcriptome landscape in glioblastoma: Incidence and therapeutic implicationsSonikpreet Aulakh, Joanne Xiu, Shawn Kothari, et al.
Neuro-Oncology Advances|January 7, 2026
Impact of systemic therapy after stereotactic radiosurgery in patients with limited brain-only metastasisJamiluddin J Qazi, Amanda E D Van Swearingen, David J Carpenter, et al.
Neuro-Oncology Advances|December 31, 2025
Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trialNikola Mikic, Slávka Lukacova, Jane Skjøth-Rasmussen, et al.
Neuro-Oncology Advances|October 30, 2025
Global lncRNA expression profiles in medulloblastoma reveal crucial lncRNA-oncogene interactions in Sonic hedgehog and Group 4Iván Martínez de Estíbariz, Unai Illarregi, Daniel Sinnett, et al.
Pageof 135